Top-level executive changes at GSK in Japan
This article was originally published in Scrip
Philippe Fauchet had been appointed president of GlaxoSmithKline in Japan, effective immediately. He succeeds Marc Dunoyer, who becomes chairman of the subsidiary. Mr Fauchet is a former president of Sanofi-Aventis in Japan, a post from which he stepped down in 2008. He was most recently a senior vice-president for business development at Sanofi-Aventis in France.
You may also be interested in...
Positive clinical results pave path forward for Japanese firm’s potential istradefylline successor.
Curon thinks tenalisib can offer a differentiated and safe new therapy for hematologic cancers such as multiple forms of lymphoma. Axis and PharmaEssentia team up on TCR therapy R&D in Taiwan.
Recent moves show Chinese biotech firms are increasingly looking to go global by recruiting world-class development talent, and J&J names new APAC pharma head.